Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE:MTEC, Frankfurt: 3CM), a leading business technology company in the cannabis space, is pleased to announce it is developing an online data and analytics portal whereby stakeholders will have the ability to gain access, explore and learn about actionable insights regarding the Canadian and global cannabis marketplace. The online data and analytics portal will feature an intuitive smart dashboard specifically designed for segments of the market with features to quickly access, process and visualize data.
“We are putting the power of data and analytics into the hands of cannabis industry stakeholders who understand its value,” said Shawn Moniz, Chief Executive Officer, Cannvas MedTech. “Like any consumer product, medical and adult-use cannabis sales in Canada and around the world are driven by individual customers. The more we know and understand about the wants and needs of the individual customer, the better the strategies and decisions we can make as to how best to identify, acquire and retain high-value customers and proactively interact with them and other market segments. We have created an industry framework for data reporting and now are creating the tool to access and process the data. We expect to generate significant revenue through Cannvas Data and our online global cannabis data and analytics portal.”
The Cannvas.Me cannabis education platform was built using contextual technology and incorporates artificial intelligence, whereby user preferences and insights are utilized to serve a fully personalized message experience through the channel of choice. As customers navigate through each individual experience, data is captured at every step of the way. Data originating from clinical and academic research, government reports and other sources are also captured by the system and included in the database.
Cannvas Data controls the data aggregation, reporting framework and online data and analytic tools to quickly manipulate vast amounts of data within an easy-to-use intuitive smart dashboard environment, to uncover market trends, hidden patterns, unknown correlations, customer preferences and other valuable business information.
About Cannvas Data
Cannvas Data is pioneering to be the social and census data of the cannabis industry by leveraging advanced technology, machine learning algorithms and scientific and medical research data to provide meaningful insights to the global cannabis community. Operating as part of the Cannvas.Me platform, Cannvas Data analyzes a multitude of data points captured from those using medical and adult-use cannabis to improve their health and wellness. The platform is LP/REC agnostic which means it is not biased by the personal drivers of any one company or institution, and it is continuously evolving and adapting to users and recognizing and learning from changing trends. For more information visit: www.cannvasdata.com
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
For additional information:
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.
For further information: Media Inquiries: firstname.lastname@example.org; Investor Relations: email@example.com, 1-800-489-0116
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).